As of 2026-10-02, the Relative Valuation of Bolt Biotherapeutics Inc (BOLT) is (243.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.51 USD, the upside of Bolt Biotherapeutics Inc based on Relative Valuation is -7029.7%.
The range of the Relative Valuation is (190.99) - (315.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 22.2x | 17.8x |
| Forward P/E multiples | 11.5x - 21.1x | 14.7x |
| Fair Price | (190.99) - (315.23) | (243.23) |
| Upside | -5541.4% - -9080.9% | -7029.7% |
| Date | P/E |
| 2026-09-30 | -0.25 |
| 2026-09-29 | -0.24 |
| 2026-09-28 | -0.23 |
| 2026-09-25 | -0.24 |
| 2026-09-24 | -0.24 |
| 2026-09-23 | -0.24 |
| 2026-09-22 | -0.25 |
| 2026-09-21 | -0.24 |
| 2026-09-18 | -0.24 |
| 2026-09-17 | -0.22 |
| 2026-09-16 | -0.24 |
| 2026-09-15 | -0.27 |
| 2026-09-14 | -0.27 |
| 2026-09-11 | -0.26 |
| 2026-09-10 | -0.25 |
| 2026-09-09 | -0.25 |
| 2026-09-08 | -0.26 |
| 2026-09-04 | -0.26 |
| 2026-09-03 | -0.26 |
| 2026-09-02 | -0.26 |
| 2026-09-01 | -0.27 |
| 2026-08-31 | -0.27 |
| 2026-08-28 | -0.25 |
| 2026-08-27 | -0.27 |
| 2026-08-26 | -0.26 |
| 2026-08-25 | -0.26 |
| 2026-08-24 | -0.25 |
| 2026-08-21 | -0.24 |
| 2026-08-20 | -0.21 |
| 2026-08-19 | -0.22 |
| 2026-08-18 | -0.21 |
| 2026-08-17 | -0.21 |
| 2026-08-14 | -0.22 |
| 2026-08-13 | -0.21 |
| 2026-08-12 | -0.23 |
| 2026-08-11 | -0.27 |
| 2026-08-10 | -0.27 |
| 2026-08-07 | -0.27 |
| 2026-08-06 | -0.26 |
| 2026-08-05 | -0.26 |
| 2026-08-04 | -0.26 |
| 2026-08-03 | -0.27 |
| 2026-07-31 | -0.27 |
| 2026-07-30 | -0.26 |
| 2026-07-29 | -0.26 |
| 2026-07-28 | -0.27 |
| 2026-07-27 | -0.27 |
| 2026-07-24 | -0.26 |
| 2026-07-23 | -0.25 |
| 2026-07-22 | -0.27 |